EICHOR
● Active Not Recruiting
HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE)
Condition: Hereditary Angioedema · Sponsor: Intellia Therapeutics
About this study
This Phase 3 study aims to evaluate the efficacy and safety of NTLA-2002 compared to placebo in participants with HAE.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (29)
| Medical Research of Arizona | Scottsdale, Arizona, United States | — |
| University of California, San Diego (UCSD) | San Diego, California, United States | — |
| Raffi Tachdjian MD, Inc | Santa Monica, California, United States | — |
| Allergy & Asthma Clinical Research | Walnut Creek, California, United States | — |
| IMMUNOe International Research Centers | Centennial, Colorado, United States | — |
| Asthma & Allergy Associates | Colorado Springs, Colorado, United States | — |
| University of South Florida | Tampa, Florida, United States | — |
| Massachusetts General Hospital | Boston, Massachusetts, United States | — |
| Washington University in St. Louis | St Louis, Missouri, United States | — |
| NYU Langone Health - Long Island | Mineola, New York, United States | — |
| Icahn School of Medicine at Mount Sinai | New York, New York, United States | — |
| Bernstein Clinical Research Center, LLC | Cincinnati, Ohio, United States | — |
+ 17 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06634420